Biogen Inc. buy BMO Capital Markets
Start price
26.07.23
/
50%
€243.00
Target price
26.07.24
€313.55
Performance (%)
-19.63%
Price
26.04.24
€195.30
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -19.63%. This prediction currently runs until 26.07.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 7.014% | 7.014% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $357.00 to $347.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat